Literature DB >> 20711196

A small-molecule inhibitor shows that pirin regulates migration of melanoma cells.

Isao Miyazaki1, Siro Simizu, Hideo Okumura, Satoshi Takagi, Hiroyuki Osada.   

Abstract

The discovery of small molecules that bind to a specific target and disrupt the function of proteins is an important step in chemical biology, especially for poorly characterized proteins. Human pirin is a nuclear protein of unknown function that is widely expressed in punctate subnuclear structures in human tissues. Here, we report the discovery of a small molecule that binds to pirin. We determined how the small molecule bound to pirin by solving the cocrystal structure. Either knockdown of pirin or treatment with the small molecule inhibited melanoma cell migration. Thus, inhibition of pirin by the small molecule has led to a greater understanding of the function of pirin and represents a new method of studying pirin-mediated signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20711196     DOI: 10.1038/nchembio.423

Source DB:  PubMed          Journal:  Nat Chem Biol        ISSN: 1552-4450            Impact factor:   15.040


  48 in total

1.  Evolution of functional diversity in the cupin superfamily.

Authors:  J M Dunwell; A Culham; C E Carter; C R Sosa-Aguirre; P W Goodenough
Journal:  Trends Biochem Sci       Date:  2001-12       Impact factor: 13.807

2.  Expanding the functional group compatibility of small-molecule microarrays: discovery of novel calmodulin ligands.

Authors:  David Barnes-Seeman; Seung Bum Park; Angela N Koehler; Stuart L Schreiber
Journal:  Angew Chem Int Ed Engl       Date:  2003-05-30       Impact factor: 15.336

3.  Microarray screening for target genes of the proto-oncogene PLAG1.

Authors:  Marianne L Voz; Janick Mathys; Karen Hensen; Hélène Pendeville; Isabelle Van Valckenborgh; Christophe Van Huffel; Marcela Chavez; Boudewijn Van Damme; Bart De Moor; Yves Moreau; Wim J M Van de Ven
Journal:  Oncogene       Date:  2004-01-08       Impact factor: 9.867

Review 4.  Introduction of new tools for chemical biology research on microbial metabolites.

Authors:  Hiroyuki Osada
Journal:  Biosci Biotechnol Biochem       Date:  2010-06-07       Impact factor: 2.043

5.  Structural and biochemical analysis reveal pirins to possess quercetinase activity.

Authors:  Melanie Adams; Zongchao Jia
Journal:  J Biol Chem       Date:  2005-06-11       Impact factor: 5.157

Review 6.  Carbonic anhydrases: novel therapeutic applications for inhibitors and activators.

Authors:  Claudiu T Supuran
Journal:  Nat Rev Drug Discov       Date:  2008-02       Impact factor: 84.694

7.  The Bcl-3 oncoprotein acts as a bridging factor between NF-kappaB/Rel and nuclear co-regulators.

Authors:  R Dechend; F Hirano; K Lehmann; V Heissmeyer; S Ansieau; F G Wulczyn; C Scheidereit; A Leutz
Journal:  Oncogene       Date:  1999-06-03       Impact factor: 9.867

8.  A tomato homologue of the human protein PIRIN is induced during programmed cell death.

Authors:  D Orzaez; A J de Jong; E J Woltering
Journal:  Plant Mol Biol       Date:  2001-07       Impact factor: 4.076

9.  Erk5 controls Slug expression and keratinocyte activation during wound healing.

Authors:  Valerie Arnoux; Mayssaa Nassour; Annie L'Helgoualc'h; Robert A Hipskind; Pierre Savagner
Journal:  Mol Biol Cell       Date:  2008-08-20       Impact factor: 4.138

10.  Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumour cells in breast cancer.

Authors:  Gang Zhu; Louise Reynolds; Tatjana Crnogorac-Jurcevic; Cheryl E Gillett; Edwin A Dublin; John F Marshall; Diana Barnes; Corrado D'Arrigo; Philippe O Van Trappen; Nicholas R Lemoine; Ian R Hart
Journal:  Oncogene       Date:  2003-06-12       Impact factor: 9.867

View more
  30 in total

1.  Pirin inhibits cellular senescence in melanocytic cells.

Authors:  Silvia Licciulli; Chiara Luise; Gaia Scafetta; Maria Capra; Giuseppina Giardina; Paolo Nuciforo; Silvano Bosari; Giuseppe Viale; Giovanni Mazzarol; Chiara Tonelli; Luisa Lanfrancone; Myriam Alcalay
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Identification of Pirin as a Molecular Target of the CCG-1423/CCG-203971 Series of Antifibrotic and Antimetastatic Compounds.

Authors:  Erika M Lisabeth; Dylan Kahl; Indiwari Gopallawa; Sarah E Haynes; Sean A Misek; Phillip L Campbell; Thomas S Dexheimer; Dinesh Khanna; David A Fox; Xiangshu Jin; Brent R Martin; Scott D Larsen; Richard R Neubig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-03-18

3.  Putative proto-oncogene Pir expression is significantly up-regulated in the spleen and kidney of cytosolic superoxide dismutase-deficient mice.

Authors:  Kamil Brzóska; Tomasz M Stępkowski; Marcin Kruszewski
Journal:  Redox Rep       Date:  2011       Impact factor: 4.412

4.  Probing small-molecule microarrays with tagged proteins in cell lysates.

Authors:  Marius S Pop; Dina Wassaf; Angela N Koehler
Journal:  Curr Protoc Chem Biol       Date:  2014-12-01

5.  Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays.

Authors:  Zufeng Guo; Zhiqiang Cheng; Jingxin Wang; Wukun Liu; Hanjing Peng; Yuefan Wang; A V Subba Rao; Ruo-Jing Li; Xue Ying; Preethi Korangath; Maria V Liberti; Yingjun Li; Yongmei Xie; Sam Y Hong; Cordelia Schiene-Fischer; Gunter Fischer; Jason W Locasale; Saraswati Sukumar; Heng Zhu; Jun O Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-10-31       Impact factor: 15.336

6.  Pirin is an iron-dependent redox regulator of NF-κB.

Authors:  Fange Liu; Imran Rehmani; Shingo Esaki; Rong Fu; Lirong Chen; Vesna de Serrano; Aimin Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

7.  A small molecule that binds and inhibits the ETV1 transcription factor oncoprotein.

Authors:  Marius S Pop; Nicolas Stransky; Colin W Garvie; Jean-Philippe Theurillat; Emily C Hartman; Timothy A Lewis; Cheng Zhong; Elizabeth K Culyba; Fallon Lin; Douglas S Daniels; Raymond Pagliarini; Lucienne Ronco; Angela N Koehler; Levi A Garraway
Journal:  Mol Cancer Ther       Date:  2014-04-15       Impact factor: 6.261

8.  PIR promotes tumorigenesis of breast cancer by upregulating cell cycle activator E2F1.

Authors:  Muhammad Suleman; Ai Chen; Huanhuan Ma; Shixiong Wen; Wentao Zhao; Donghai Lin; Guode Wu; Qinxi Li
Journal:  Cell Cycle       Date:  2019-09-10       Impact factor: 4.534

Review 9.  Recent discoveries and applications involving small-molecule microarrays.

Authors:  Jiyoung A Hong; Dylan V Neel; Dina Wassaf; Francisco Caballero; Angela N Koehler
Journal:  Curr Opin Chem Biol       Date:  2013-11-27       Impact factor: 8.822

10.  Inhibition of the Myocardin-Related Transcription Factor Pathway Increases Efficacy of Trametinib in NRAS-Mutant Melanoma Cell Lines.

Authors:  Kathryn M Appleton; Charuta C Palsuledesai; Sean A Misek; Maja Blake; Joseph Zagorski; Kathleen A Gallo; Thomas S Dexheimer; Richard R Neubig
Journal:  Cancers (Basel)       Date:  2021-04-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.